Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Patient
|
June 26, 2026
Probabilistic Attribute Presentation in Discrete Choice Experiments: A Scoping Review of Current Practice
Gabriela S Fernandez, Saudamini Oke, Matt Quaife
The Patient
|
December 15, 2023
Preferences of Patients with Amyotrophic Lateral Sclerosis for Intrathecal Drug Delivery: Choosing between an Implanted Drug-Delivery Device and Therapeutic Lumbar Puncture
Jaein Seo, Sandeep Saurkar, Gabriela S Fernandez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 9, 2022
Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry
Sylvia Szentpetery, Gabriela S Fernandez, Michael S Schechter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 28, 2022
Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening
Gregory A Ratti, Gabriela S Fernandez, Michael S Schechter, et al.
Leukemia & Lymphoma
|
April 10, 2026
Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study
Christine Michaels-Igbokwe, Hui Lu, Katherine B Winfree, et al.
Pharmacoeconomics - Open
|
August 28, 2024
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
Alexander Keenan, Chiara Whichello, Hoa H Le, et al.
The Patient
|
May 15, 2024
Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
Alexander Keenan, Chiara Whichello, Hoa H Le, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 29, 2025
Patient and oncologist preferences for ALK+ advanced non-small cell lung cancer tyrosine kinase inhibitor treatments: a discrete choice experiment in the United States
Hannah Le, Josh Coulter, Ken Culver, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Patient
|
June 26, 2026
Probabilistic Attribute Presentation in Discrete Choice Experiments: A Scoping Review of Current Practice
Gabriela S Fernandez, Saudamini Oke, Matt Quaife
The Patient
|
December 15, 2023
Preferences of Patients with Amyotrophic Lateral Sclerosis for Intrathecal Drug Delivery: Choosing between an Implanted Drug-Delivery Device and Therapeutic Lumbar Puncture
Jaein Seo, Sandeep Saurkar, Gabriela S Fernandez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 9, 2022
Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry
Sylvia Szentpetery, Gabriela S Fernandez, Michael S Schechter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 28, 2022
Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening
Gregory A Ratti, Gabriela S Fernandez, Michael S Schechter, et al.
Leukemia & Lymphoma
|
April 10, 2026
Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study
Christine Michaels-Igbokwe, Hui Lu, Katherine B Winfree, et al.
Pharmacoeconomics - Open
|
August 28, 2024
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
Alexander Keenan, Chiara Whichello, Hoa H Le, et al.
The Patient
|
May 15, 2024
Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
Alexander Keenan, Chiara Whichello, Hoa H Le, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 29, 2025
Patient and oncologist preferences for ALK+ advanced non-small cell lung cancer tyrosine kinase inhibitor treatments: a discrete choice experiment in the United States
Hannah Le, Josh Coulter, Ken Culver, et al.
Page
of 1